EA199800533A1 - COMPOSITION FOR THE TREATMENT OF PAIN - Google Patents
COMPOSITION FOR THE TREATMENT OF PAINInfo
- Publication number
- EA199800533A1 EA199800533A1 EA199800533A EA199800533A EA199800533A1 EA 199800533 A1 EA199800533 A1 EA 199800533A1 EA 199800533 A EA199800533 A EA 199800533A EA 199800533 A EA199800533 A EA 199800533A EA 199800533 A1 EA199800533 A1 EA 199800533A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- composition
- pain
- treatment
- compounds
- opioids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Настоящее изобретение представляет композицию и способ лечения боли, использующий композицию, включающую Избранные Мускариновые Соединения и одно или более соединений, выбранных из группы, состоящей из Нестероидных Противовоспалительных препаратов, ацетаминофена, опиоидов и альфа-адренергических соединений.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention provides a composition and method for treating pain using a composition comprising Selected Muscarinic Compounds and one or more compounds selected from the group consisting of Non-steroidal Anti-inflammatory Drugs, acetaminophen, opioids, and alpha adrenergic compounds. search.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US829995P | 1995-12-07 | 1995-12-07 | |
PCT/US1996/019309 WO1997020561A1 (en) | 1995-12-07 | 1996-12-05 | Composition for treating pain |
Publications (1)
Publication Number | Publication Date |
---|---|
EA199800533A1 true EA199800533A1 (en) | 1999-02-25 |
Family
ID=21730869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199800533A EA199800533A1 (en) | 1995-12-07 | 1996-12-05 | COMPOSITION FOR THE TREATMENT OF PAIN |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0871445A4 (en) |
JP (1) | JP2000501709A (en) |
KR (1) | KR19990071976A (en) |
CN (1) | CN1208349A (en) |
AU (1) | AU705031B2 (en) |
CA (1) | CA2238815A1 (en) |
CZ (1) | CZ174698A3 (en) |
EA (1) | EA199800533A1 (en) |
IL (1) | IL124419A0 (en) |
NO (1) | NO982562L (en) |
NZ (1) | NZ324988A (en) |
PL (1) | PL327137A1 (en) |
WO (1) | WO1997020561A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998046227A1 (en) * | 1997-04-11 | 1998-10-22 | Eli Lilly And Company | Composition for treating pain |
ATE248166T1 (en) | 1999-06-04 | 2003-09-15 | Lilly Co Eli | 7-OXO-2-AZABICYCLO(2.2.1)HEPTANES AS SELECTIVE MUSCARINE RECEPTOR ANTAGONISTS |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
DK3169315T3 (en) | 2014-07-17 | 2020-08-10 | Pharmaceutical Manufacturing Res Services In | Liquid-filled dosage form to prevent immediate release abuse |
US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2998450A (en) * | 1958-05-19 | 1961-08-29 | Warner Lambert Pharmaceutical | Process of preparing nu-acetyl-p-amino phenol |
GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
US5260293A (en) * | 1988-01-30 | 1993-11-09 | Merck Sharp & Dohme Limited | Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia |
IL89351A0 (en) * | 1988-03-14 | 1989-09-10 | Lundbeck & Co As H | 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
WO1995025511A1 (en) * | 1994-03-18 | 1995-09-28 | Bayer Corporation | Low dosage ketoprofen |
-
1996
- 1996-12-05 CA CA002238815A patent/CA2238815A1/en not_active Abandoned
- 1996-12-05 CN CN96199837A patent/CN1208349A/en active Pending
- 1996-12-05 AU AU12791/97A patent/AU705031B2/en not_active Ceased
- 1996-12-05 KR KR1019980704267A patent/KR19990071976A/en not_active Application Discontinuation
- 1996-12-05 WO PCT/US1996/019309 patent/WO1997020561A1/en not_active Application Discontinuation
- 1996-12-05 NZ NZ324988A patent/NZ324988A/en unknown
- 1996-12-05 EP EP96943584A patent/EP0871445A4/en not_active Withdrawn
- 1996-12-05 PL PL96327137A patent/PL327137A1/en unknown
- 1996-12-05 EA EA199800533A patent/EA199800533A1/en unknown
- 1996-12-05 JP JP9521397A patent/JP2000501709A/en active Pending
- 1996-12-05 CZ CZ981746A patent/CZ174698A3/en unknown
- 1996-12-05 IL IL12441996A patent/IL124419A0/en unknown
-
1998
- 1998-06-04 NO NO982562A patent/NO982562L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1208349A (en) | 1999-02-17 |
IL124419A0 (en) | 1998-12-06 |
CZ174698A3 (en) | 1998-10-14 |
NZ324988A (en) | 1999-08-30 |
KR19990071976A (en) | 1999-09-27 |
WO1997020561A1 (en) | 1997-06-12 |
NO982562D0 (en) | 1998-06-04 |
PL327137A1 (en) | 1998-11-23 |
EP0871445A4 (en) | 2001-01-10 |
CA2238815A1 (en) | 1997-06-12 |
NO982562L (en) | 1998-07-10 |
EP0871445A1 (en) | 1998-10-21 |
AU1279197A (en) | 1997-06-27 |
JP2000501709A (en) | 2000-02-15 |
AU705031B2 (en) | 1999-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE122009000012I1 (en) | Substituted pyrazolylbenzenesulfonamides for the treatment of inflammation. | |
DE59611411D1 (en) | USE OF ALPHA 1L AGONISTS FOR THE TREATMENT OF HARNINE CONTINENCE | |
EA200000220A1 (en) | COMBINATION OF TYROSINKINASE INHIBITOR AND CHEMICAL STERILIZATION FOR TREATMENT OF PROSTATE GLAND | |
ATE234092T1 (en) | 2-ALKYLPYRROLIDINE | |
DE69626864D1 (en) | Wastewater basin FOR AEROBIC TREATMENT OF WASTEWATER, including carrier | |
DE69427869D1 (en) | BOTULINUMTOXINS FOR TREATING HYPERHYDROSIS | |
ATE295519T1 (en) | TREATMENT OF HYDROCARBON GAS | |
ES2178157T3 (en) | TREATMENT OF ARRITMIAS THROUGH THE INHIBITION OF A MULTIFUNCTIONAL KINASE PROTEIN DEPENDENT ON CALCIUM / CALMODULIN. | |
DE69707033D1 (en) | Process for the treatment of gases containing organohalogen compositions | |
DE69423131D1 (en) | Process for the treatment of sputum containing mycobacteria | |
ATE267187T1 (en) | DIHYDROBENZOFURANES AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS | |
DE69405919D1 (en) | Compositions for the treatment of keratin fibers | |
HUP9700598A2 (en) | Process for producing pharmaceutical composition useful for profilacting and treating pancreatitis | |
EA199800533A1 (en) | COMPOSITION FOR THE TREATMENT OF PAIN | |
DE69737067D1 (en) | VACCINE FOR THE TREATMENT OF MYCOSES | |
PT1024809E (en) | UTILIZATION OF IMMUNOMODULATION AGENTS | |
ATE225171T1 (en) | AMINO ACID DERIVATIVES FOR THE TREATMENT OF STROKE | |
DE69607559T2 (en) | Process for the treatment of phenol tar | |
EA199800535A1 (en) | METHOD OF TREATMENT OF PAIN | |
DE69706758T2 (en) | Process for the treatment of polyolefin | |
HUP9701618A2 (en) | Pharmaceutical composition containing tramadol and a calcium-canal-antagonist | |
NO20005548L (en) | Mykobakterieinhibitorer | |
ES2190581T3 (en) | 2-OPTICALLY ACTIVE AMINOTETRALINE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ACTIVE IN THE PREVENTION AND TREATMENT OF SEPTIC SHOCK. | |
DE69737088D1 (en) | THERAPEUTIC AGENT FOR THE TREATMENT OF FIV INFECTIONS | |
BR9703403B1 (en) | compounds, process for preparing compounds, use of compound and process for preparing pharmaceutical composition. |